ARTELO BIOSCIENCES, INC. — Form 8-K Summary
Reporting date: October 9, 2026. The filing reports an exchange-listing compliance development; it does not report quarterly or annual financial results.
Business context and financial information
Artelo Biosciences, Inc. is a Nevada corporation whose common stock trades on Nasdaq under ticker ARTL. The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
Nasdaq listing rule and developments
- The SEC approved a Nasdaq rule on July 22, 2026, requiring listed companies to maintain at least $5 million in market value of listed securities (MVLS). Companies below the threshold may face delisting proceedings unless they demonstrate a plan to regain compliance within a specified period.
- Artelo was among approximately 180 Nasdaq-listed companies initially identified as below the threshold.
- A temporary stay was announced on July 29, 2026. On October 5, Nasdaq proposed making the rule operative when the stay ends; comments are due October 29, 2026.
- As of the filing, the company did not know how long the stay would last, whether the rule would return in its current form, or whether it would be modified.
Management plans and risks
Artelo intends to monitor developments and, if an applicable rule takes effect, consider ways to regain or maintain compliance. Potential steps could include raising capital through its existing at-the-market offering program or other equity or equity-linked financings, actions involving outstanding warrants or other securities, advancing development programs, managing expenses, or other corporate actions. The company has committed to no specific action, and gives no assurance that any action would achieve or maintain compliance. It does not intend to disclose further developments unless disclosure is appropriate or required.
Key facts for investors to verify
- Whether and when the temporary stay ends, and the final form and effective date of the $5 million MVLS rule.
- Artelo’s MVLS and Nasdaq compliance status at the relevant time; this filing does not state a specific MVLS amount.
- Any subsequent company action, financing, or Nasdaq notice related to compliance.